Sovran Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Sovran Advisors, LLC
- $954 Billion
- Q2 2025
A detailed history of Sovran Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sovran Advisors, LLC holds 1,385 shares of VRTX stock, worth $638,249. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,385
Previous 5,489
74.77%
Holding current value
$638,249
Previous $2.68 Billion
75.94%
% of portfolio
0.07%
Previous 0.35%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,826Shares Held
231MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$13.1 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.82 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.7 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.43 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $118B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...